We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Envigo Invests in Science and Technology Advisory Group

News   Sep 26, 2016

 
Envigo Invests in Science and Technology Advisory Group
 
 
Advertisement
 

RELATED ARTICLES

Large Trial To Investigate Repurposed Drugs To Treat Mild-to-Moderate COVID-19

News

The large, randomized, placebo‑controlled Phase 3 clinical trial will explore up to seven drugs approved by US Food and Drug Administration (FDA) for other conditions – an approach called drug repurposing – and test their safety and effectiveness in treating mild-to-moderate COVID-19.

READ MORE

Team Uncovers the Mechanism Behind Toxicity of USP7 Inhibitors

News

A new study has uncovered a cell cycle control element, the USP7 protein. It acts as a brake to prevent cells from dividing until the process of copying genetic material has been completed, and it also monitors this copying process to ensure that it happens correctly.

READ MORE

Experimental Drug MK-4482 for COVID-19 Is Effective in Hamster Study

News

The experimental antiviral drug MK-4482 was shown to significantly decrease levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE